Jci_page_head_homepage_01 Jci_page_head_homepage_02
Olga A. Mareninova, Kip Hermann, Samuel W. French, Mark S. O’Konski, Stephen J. Pandol, Paul Webster, Ann H. Erickson, Nobuhiko Katunuma, Fred S. Gorelick, Ilya Gukovsky, Anna S. Gukovskaya
Published in Volume 119, Issue 11
J Clin Invest. 2009; 119(11):3340–3355 doi:10.1172/JCI38674
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
CatL but not CatB inhibits trypsin activity by degrading both trypsin and trypsinogen.

(AC) Effects of CatB and CatL on trypsinogen activation and degradation in cell-free system. Trypsinogen (A) or trypsin (B) was incubated for 2 hours with and without CatB or CatL, as described in Methods, and trypsin activity was measured by a fluorogenic assay. (C). Levels of trypsinogen and trypsin remaining after the 2-hour incubation with CatB or CatL were measured by immunoblot. (D) Rat pancreatic acinar cells were incubated for 30 minutes with and without 100 nM CCK, in the presence and absence of the specific CatL inhibitor CLIK-148 (20 mM). Trypsin activity was measured by a fluorogenic assay. Values in A, B, and D are mean ± SEM (n = 3). *P < 0.05 versus control cells; #P < 0.05 versus CCK alone. (E). Schematic illustrating the hypothesis that the pathological, intra-acinar trypsin accumulation results from an imbalance between the activities of CatB, which converts trypsinogen to trypsin, and CatL, which degrades both trypsin and trypsinogen. The stimulatory and inhibitory effects of pancreatitis on these enzymes are shown by (+) and (–) symbols, respectively.